CrossBridge Bio raised $10M in seed financing led by TMC Venture Fund and CE-Ventures to advance the development of next-generation dual-payload ADC therapies.
Nov 04, 2024•about 1 year ago
Amount Raised
$10 Million
Round Type
seed
HoustonTherapeuticsBiotechnologyHealth CareInvestors
Linden Lake LabsAlexandria Venture InvestmentsPortal InnovationsCe VenturesTmc Venture Fund
Description
CrossBridge Bio, a biotechnology company, has secured $10 million in seed financing. The funds will support the development of their lead program and expand their pipeline of novel ADC programs targeting cancer therapies.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech